2nd Annual Gene and Cell Therapy: Quality Developments to Commercialization Virtual Summit

<img width="1784" height="923" src="https://www.njii.com/wp-content/uploads/2020/10/2nd-annual-cell-and-gene-therapy.png" class="attachment-full-size size-full-size wp-post-image" alt="2nd Annual Gene and Cell Therapy: Quality Developments to Commercialization Virtual Summit" decoding="async" fetchpriority="high" srcset="https://www.njii.com/wp-content/uploads/2020/10/2nd-annual-cell-and-gene-therapy.png 1784w, https://www.njii.com/wp-content/uploads/2020/10/2nd-annual-cell-and-gene-therapy-600x310.png 600w, https://www.njii.com/wp-content/uploads/2020/10/2nd-annual-cell-and-gene-therapy-1024x530.png 1024w, https://www.njii.com/wp-content/uploads/2020/10/2nd-annual-cell-and-gene-therapy-768x397.png 768w, https://www.njii.com/wp-content/uploads/2020/10/2nd-annual-cell-and-gene-therapy-1536x795.png 1536w, https://www.njii.com/wp-content/uploads/2020/10/2nd-annual-cell-and-gene-therapy-100x52.png 100w, https://www.njii.com/wp-content/uploads/2020/10/2nd-annual-cell-and-gene-therapy-1184x613.png 1184w" sizes="(max-width: 1784px) 100vw, 1784px" />

Biopharma

2nd Annual Gene and Cell Therapy: Quality Developments to Commercialization Virtual Summit

10/26/2020 to 10/27/2020 Virtual

Alex Klarer, Head of Cell Therapy Development at BioCentriq will be speaking.